Treating BPH: Comparing Rezum UroLift and HoLEP
|
|
- Hilda Watson
- 5 years ago
- Views:
Transcription
1 Treating BPH: Comparing Rezum UroLift and HoLEP Scott M. Cheney MD Mayo Clinic Arizona 2018 MFMER slide-1
2 Welcome to AZ 2018 MFMER slide-2
3 Outline Background on BPH, Rezum, Urolift, HoLEP AUA Guideline Statements Level of Evidence Comparative Outcomes Functional Sexual Complications Durability/Retreatment Decision-Making 2018 MFMER slide-3
4 Disclosures None 2018 MFMER slide-4
5 Audience Question #1 What is the gold standard for surgical treatment of BPH? 1. Urolift 2. Rezum 3. TURP 4. Green Light PVP 5. HoLEP/ThuLEP 6. Other 2018 MFMER slide-5
6 Background 2018 MFMER slide-6
7 BPH Disease Prevalence 15 million men >30y affected by BPH Lee Eur Urol 1998 Olmstead County Study 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% Moderate-Severe LUTS (AUA > 7) 40-49y 50-59y 60-69y 70-79y Chute J Urol MFMER slide-7
8 Definitions MIST- Minimally Invasive Surgical Therapy Urolift- Prostatic Urethral Lift PUL Rezum- Water Vapor Thermal Therapy Definitive Therapy- Tissue removal HoLEP- Holmium Laser Enucleation of the Prostate Comparing apples to apples? 2018 MFMER slide-8
9 BPH Treatment Options Observation Dietary Supplements Medication Alpha Blockers 5-ARI PDE-5I Minimally Invasive Surgery TUMT TUNA Rezum (Steam vapor) UroLift Definitive Surgery TURP TUIP HoLAP PVP (Green light) HoLEP/ThuLEP Open Simple Prostatectomy Robotic Simple Prostatectomy 2018 MFMER slide-9
10 MIST Rezum (NxThera, Maple Grove, MN) Radiofrequency energy à Steam à Tissue Necrosis à Decreased TZ Volume FDA approval August 2015 Can be used on median lobe 2018 MFMER slide-10
11 MIST Urolift (Neotract, Pleasanton, CA) FDA Approval Sept 2013 Ideal for patients without median lobe 2018 MFMER slide-11
12 Definitive Therapy HoLEP First Described 1995 Gilling J Endourol 1995 All prostate sizes, configurations Adenoma separated from prostate capsule Enucleated tissue morcellated in the bladder Fraundorfer, Gilling. Eur Urol MFMER slide-12
13 2018 AUA Guideline Statements Urolift 14. Clinicians should consider PUL (Prostatic Urethral Lift) as an option for patients with LUTS attributed to BPH provided prostate volume <80 and verified absence of an obstructive middle lobe; however, patients should be informed that symptom reduction and flow rate improvement is less significant compared to TURP. (Grade C, Moderate Recommendation) 15. PUL may be offered to eligible patients concerned with erectile and ejaculatory function for the treatment of with LUTS attributed to BPH. (Grade C, Conditional Recommendation) 2018 MFMER slide-13
14 2018 AUA Guideline Statements Rezum 17. Water vapor thermal therapy (Rezum) may be offered to patients with LUTS attributed to BPH provided prostate volume <80g; however, patients should be informed that evidence of efficacy, including longer-term retreatment rates, remains limited. (Grade C, Conditional Recommendation) 18. Water vapor thermal therapy may be offered to eligible patients who desire preservation of erectile and ejaculatory function. (Grade C, Conditional Recommendation) 2018 MFMER slide-14
15 2018 AUA Guideline Statements HoLEP 20. Clinicians should consider holmium laser enucleation of the prostate (HoLEP) or thulium laser enucleation of the prostate (ThuLEP), depending on their expertise with either technique, as prostate size-independent suitable options for the treatment of LUTS attributed to BPH. (Grade B, Moderate Recommendation) 22. HoLEP, PVP, and ThuLEP should be considered in patients who are at higher risk of bleeding, such as those on anti-coagulation drugs. (Expert Opinion) 2018 MFMER slide-15
16 Level of Evidence Urolift Years of experience- 5 Randomized trials- 2 Rezum Years of experience- 3 Randomized trials- 1 HoLEP Years of experience- 20 Randomized trials MFMER slide-16
17 Audience Question #2 What is the most important factor the patient considers when choosing type of BPH surgery? 1. Efficacy/ Degree of improvement 2. Risk of sexual side effects (ED, EjD) 3. Risk of retreatment 4. Risk of incontinence 5. Time of catheterization 6. Cost 2018 MFMER slide-17
18 Audience Question #3 What is the most important factor the surgeon considers when choosing BPH surgery? 1. Efficacy/ Degree of improvement 2. Risk of sexual side effects (ED, EjD) 3. Risk of retreatment 4. Risk of incontinence 5. Time of catheterization 6. Cost 2018 MFMER slide-18
19 Outcomes 2018 MFMER slide-19
20 Functional Outcomes IPSS UroLift Rezum HoLEP Baseline (out of 35) mo mo Long Term -8 (60 mo) -11 (36 mo) -18 (92 mo) Roehrborn (L.I.F.T.) Can J Urol 2017 Gratzke BJUI (BPH6) 2017 McVary Urol 2018 Gilling BJUI MFMER slide-20
21 Functional Outcomes IPSS-QOL UroLift Rezum HoLEP Baseline (out of 6) mo mo Long Term -2.1 (60 mo) -2.2 (36 mo) -3.3 (92 mo) Roehrborn (L.I.F.T.) Can J Urol 2017 Gratzke BJUI (BPH6) 2017 McVary Urol 2018 Gilling BJUI MFMER slide-21
22 Functional Outcomes Qmax UroLift Rezum HoLEP Baseline (ml/s) mo mo Long Term +3 (60 mo) +3.5 (36 mo) +14 (92 mo) Roehrborn (L.I.F.T.) Can J Urol 2017 Gratzke BJUI (BPH6) 2017 McVary Urol 2018 Gilling BJUI MFMER slide-22
23 Sexual Outcomes Urolift No de novo ED Same or improved ejaculatory function No change in IIEF or MSHQ- EjD scores Rezum No de novo ED 2% pts with reduced ejaculatory volume No change in IIEF or MSHQ- EjD scores AUA BPH Guideline 2018 AUA BPH Guideline 2018 HoLEP IIEF- Erection (out of 30) : Baseline 22.3 à 23.8 (1y) IIEF- Orgasm (out of 10): Baseline 8.5 à 6.5 (1y) IIEF- Overall Satisfaction (out of 10): Baseline 7.2 à 7.1 (1y) Montorsi J Urol 2008 Retrograde Ejaculation 74-85% Krambeck Curr Op Urol MFMER slide-23
24 Complications UroLift Rezum HoLEP SUI NR NR % (3mo) 1% (>1y) Urgency/UUI 3% 5.9% 44% Dysuria 9% 16.9% 59% Acute Retention 0.4% 3.7% 5.3% Stricture <0.01% % (1y) Transfusion NR NR 1.6% Roehrborn Can J Urol 2017 McVary Urol 2018 Krambeck Curr Op Urol 2018, Montorsi J Urol MFMER slide-24
25 Retreatment Rate Urolift Surgery for BPH symptom recurrence- 19/140 (13.5% at 5 years) Removal encrusted implants- 10/140 (7.1%) Removal implants in bladder- 3/140 (2.1%) Restarted alpha blocker/5-ari- 15/140 (10.7%) AUA BPH Guidelines 2018 Rezum Surgery for BPH symptom recurrence- 6/135 (4.4% at 3 years) HoLEP McVary Urol 2018 Surgery for symptomatic residual/adenoma regrowth- 0.5% Krambeck Curr Op Urol MFMER slide-25
26 Special Considerations Length of catheterization Urolift- 0.9d Roehrborn Can J Urol 2017 Rezum- 4.1d Dixon Res Rep Urol 2016 HoLEP- 18h Gilling BJUI 2011 Learning Curve Urolift- 5 cases Roehrborn Interview Uro Today 2017 Rezum cases NxThera Website HoLEP cases Krambeck Curr Op Urol 2018 Anesthesia Rezum/Urolift- Local or General HoLEP- General Only, 125min operative time Krambeck Curr Op Urol MFMER slide-26
27 Cost Ulchaker ClinicoEcon MFMER slide-27
28 Decision Making 2018 MFMER slide-28
29 Definitive Therapy HoLEP Invasiveness Medical Therapy 5-ARI α-blockers Qmax- +2.4mL/s IPSS AUR/BPH Surgery- 11.9% Incontinence- 3% EjD- 17% MIST Rezum Urolift Qmax- +3.5mL/s IPSS Def Surgery % Incontinence- 0% EjD- 0-2% Qmax- +14mL/s IPSS- -18 Retreatment- 0.5% Incontinence- 1-3% EjD- 80% Roehrborn BJUI 2018, Montorsi (CombAT) BJUI 2011, Roehrborn (CombAT) Eur Urol 2010, Effectiveness 2018 MFMER slide-29
30 2018 MFMER slide-30
31 Summary Must weigh efficacy, invasiveness, cost, skill-set Urolift and Rezum have similar efficacy, low complication rate, reasonable durability Urolift and Rezum preserve sexual/ejaculatory function Urolift and Rezum should be used for prostate volume <80gm HoLEP has higher efficacy and lower retreatment rate, but is more invasive and has more side effects HoLEP can be used for any size prostate HoLEP should be considered for patients with higher bleeding risk 2018 MFMER slide-31
32 Conclusion Every urologist should have several surgical tools at his/her disposal to address unique patient considerations: Symptoms, Anatomy, Efficacy, Comorbidities, Side Effects 2018 MFMER slide-32
33 References American Urological Association Guideline: Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (2018). Chute C, Panser L, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150(1):85. Dixon C, Edwin R, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol 2016:8: Gilling P, Wilson L, et al. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJUI 2011;109: Gratzke C, Barber N, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJUI 2017;119: Large T, Krambeck A. Evidence-based outcomes of holmium laser enucleation of the prostate. Curr Op Urol 2018;28: Lee A, Garraway W, Simpson R, et al. The natural history of untreated lower urinary tract symptoms in middle-aged and elderly men over a period of five years. Eur Urol 1998;34: McVary K, Roehrborn C. Rezum System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Urology 2018;111:1-9. Montorsi F, Naspro R, et al. Holmium laser enucleation versus transurethral resection of the prostate: Results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2008;179: S87 S90. Montorsi F, Roehrborn C, et al. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study. BJUI 2011;107: Roehrborn C, Barkin J, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 2017; 24(3): Roehrborn C. AUA 2017: Minimally Invasive Prostatic Urethral Lift (PUL) Produces Durable Symptom Improvement in Lower Urinary Tract Symptoms: Interview with Claus Roehrborn. Uro Today. bph/95787-minimally-invasive-prostatic-urethral-lift-pul-produces-durable-symptom-improvement-in-lower-urinary-tract-infectionsinterview-with-claus-roehrborn.html Roehrborn C, Manyak M, et al. A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJUI 2018; 121: Roehrborn C, Siami P, et al. The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study. Eur Urol 2010;57: Ulchaker J, Martinson M. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Clin Econ Outc Res 2018; MFMER slide-33
34 Thank you! 2018 MFMER slide-34
Benign Prostatic Hyperplasia: Update on Innovative Current Treatments
Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Michael Ferrandino, MD As.soc Professor Director of Minimally Invasive Urologic Surgery Division of Urologic Surgery Duke University
More informationNOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate
NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with
More informationConvective RF Water Vapor Energy Ablation Effectively Treats LUTS due to BPH, Preserves Erectile and Ejaculatory Function
1 Convective RF Water Vapor Energy Ablation Effectively Treats LUTS due to BPH, Preserves Erectile and Ejaculatory Function Nikhil Gupta, Tobias S. Köhler, Kevin T. McVary SIU School of Medicine Division
More informationThe Enlarged Prostate Symptoms, Diagnosis and Treatment
The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda
More informationRezūm procedure for the Prostate
Rezūm procedure for the Prostate Mr Jas Kalsi Consultant Urological Surgeon This booklet has been provided to help answer the questions you may have with regards to your enlarged prostate and the Rezūm
More informationBenign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome
More informationRezum: A New Non Invasive Promise for Benign Prostate Hyperplasia Treatment
Human Journals Review Article November 2018 Vol.:13, Issue:4 All rights are reserved by Babitha. M et al. Rezum: A New Non Invasive Promise for Benign Prostate Hyperplasia Treatment Keywords: BPH, LUTS,
More informationProstatic Urethral Lift
Prostatic Urethral Lift Policy Number: 7.01.151 Last Review: 10/2018 Origination: 10/2015 Next Review: 10/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Prostatic
More informationBenign Prostatic Hyperplasia (BPH) Treatments
Medical Coverage Policy Effective Date...10/15/2017 Next Review Date...10/15/2018 Coverage Policy Number... 0159 Benign Prostatic Hyperplasia (BPH) Treatments Table of Contents Related Coverage Resources
More informationPOLICIES AND PROCEDURE MANUAL
POLICIES AND PROCEDURE MANUAL Policy: MP048 Section: Medical Benefit Policy Subject: Surgical and Minimally Invasive Therapies for the Treatment of Benign Prostatic Hypertrophy I. Policy: Surgical and
More informationProstatic Urethral Lift. Summary
Section: Surgery Effective Date: January 15, 2017 Subject: Prostatic Urethral Lift Page: 1 of 10 Last Review Status/Date: December 2016 Prostatic Urethral Lift Summary Benign prostatic hyperplasia (BPH)
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Prostatic Urethral Lift Page 1 of 19 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Prostatic Urethral Lift Professional Institutional Original Effective Date:
More informationPATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A
PATIENT INFORMATION OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have
More informationOverview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014
Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of insertion of prostatic urethral lift implants to treat lower urinary tract symptoms
More informationRelated Policies None
Medical Policy MP 7.01.151 BCBSA Ref. Policy: 7.01.151 Last Review: 12/27/2017 Effective Date: 03/01/2018 Section: Surgery End Date: 08/19/2018 Related Policies None DISCLAIMER Our medical policies are
More informationOVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1
PATIENT INFORMATION BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have to be one of them! OVER 70% OF MEN IN THEIR 60s HAVE
More informationRelated Policies None
Medical Policy MP 7.01.151 Original Policy Date: August 2015 Last Review: 12/27/2017 Effective Date: 03/01/2018 Section: Surgery Related Policies None DISCLAIMER Our medical policies are designed for informational
More informationREVIEW. Introduction. Accepted for publication January 2018
REVIEW Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy Hannah Pham, Pranav Sharma, MD Department of Urology, Texas Tech University Health
More informationTransurethral Laser Technology: Treatments for BPH
Transurethral Laser Technology: Treatments for BPH Richard Lee, MD Departments of Urology and Public Health The New York Presbyterian Hospital Weill Medical College of Cornell University Background Traditional
More informationBenign Prostatic Hyperplasia (BPH):
Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate
More informationNumber: Policy *Please see amendment for Pennsylvania Medicaid at the end of
1 of 54 Number: 0079 Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB. I. Aetna considers the following approaches to the treatment of benign prostatic hypertrophy (BPH) medically
More informationLast Review Status/Date: December Summary
Section: Surgery Effective Date: January 15, 2016 Subject: Prostatic Urethral Lift Page: 1 of 9 Last Review Status/Date: December 2015 Summary Benign prostatic hyperplasia (BPH) is a common condition in
More informationSubject: Temporary Prostatic Stent and Prostatic Urethral Lift
02-54000-21 Original Effective Date: 03/15/05 Reviewed: 09/27/18 Revised: 10/15/18 Subject: Temporary Prostatic Stent and Prostatic Urethral Lift THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION,
More informationPROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA
St. Louis Hospital PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA INITIAL CLINICAL RESULTS Faculty of Medical Sciences New University of Lisbon JOÃO PISCO LUÍS CAMPOS PINHEIRO TIAGO BILHIM HUGO RIO TINTO
More informationProstatic Urethral Lift
Protocol Prostatic Urethral Lift (701151) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization No Review Dates: 05/17, 01/18 Preauthorization is not required. The following
More informationMale Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon
Male Lower Urinary Tract Symptoms: Management in primary care and beyond Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon 1 LUTS Very common: 1/3 men over age of 50 have moderate to severe LUTS
More informationUroLift for treating the symptoms of benign prostatic hyperplasia
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Medical technology guidance Assessment report overview UroLift for treating the symptoms of benign prostatic hyperplasia This assessment report overview
More informationMedical technologies guidance Published: 16 September 2015 nice.org.uk/guidance/mtg26
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia Medical technologies guidance Published: 16 September 2015 nice.org.uk/guidance/mtg26 NICE 2018. All rights reserved. Subject
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of transurethral water vapour ablation for lower urinary tract symptoms caused by
More informationAuthor's Accepted Manuscript
Author's Accepted Manuscript Convective Radiofrequency Water Vapor Thermal Therapy with Rezūm System: Durable Two-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Prostatic Urethral Lift Page 1 of 17 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Prostatic Urethral Lift Professional Institutional Original Effective Date:
More informationLong-term Follow-up of Transurethral Enucleation Resection of the Prostate for Symptomatic Benign Prostatic Hyperplasia
Journal of Surgery 2016; 4(2): 40-44 http://www.sciencepublishinggroup.com/j/js doi: 10.11648/j.js.20160402.18 ISSN: 2330-0914 (Print); ISSN: 2330-0930 (Online) Long-term Follow-up of Transurethral Enucleation
More informationPeter T. Chin, Damien M. Bolton, Greg Jack, Prem Rashid, Jeffrey Thavaseelan, R. James Yu, Claus G. Roehrborn, and Henry H. Woo
Rapid Communication Prostatic Urethral Lift: Two-year Results After Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia Peter T. Chin, Damien M. Bolton, Greg Jack, Prem
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Medical technology guidance SCOPE The UroLift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia 1
More informationOriginal Policy Date
MP 7.01.39 Transurethral Microwave Thermotherapy Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical
More informationUroLift for treating lower urinary tract
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Medical technology consultation document UroLift for treating lower urinary tract The National Institute for Health and Care Excellence (NICE) is producing
More informationOriginal Article HoLEP: the gold standard for the surgical management of BPH in the 21 st Century
Am J Clin Exp Urol 2015;3(1):36-42 www.ajceu.us /ISSN:2330-1910/AJCEU0007305 Original Article HoLEP: the gold standard for the surgical management of BPH in the 21 st Century John Michalak, David Tzou,
More informationBPH OVERVIEW / MANAGEMENT. Richard L Haddad Norwest Private Hospital 17 Oct 2018
BPH OVERVIEW / MANAGEMENT Richard L Haddad Norwest Private Hospital 17 Oct 2018 Introduction Learning outcomes; Develop a management plan for BPH patients Describe the new medical therapies in BPH and
More informationWhat is Benign Prostatic Hyperplasia (BPH)?
What is Benign Prostatic Hyperplasia (BPH)? Benign prostatic hyperplasia (BPH) is an enlarged prostate. The prostate goes through two main growth periods as a man ages. The first occurs early in puberty,
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: April 15, 2018 Related Policies: None Prostatic Urethral Lift Description Benign prostatic hyperplasia (BPH) is a common condition in older individuals that can
More informationAN OVERVIEW OF THE MANAGEMENT OF MALE LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC OBSTRUCTION
AN OVERVIEW OF THE MANAGEMENT OF MALE LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC OBSTRUCTION *Richard Christian Rowan Nayar, Hashim Hashim Continence and Urodynamics Unit, Bristol Urological Institute,
More informationOriginal Article - Lasers in Urology. Min Ho Lee, Hee Jo Yang, Doo Sang Kim, Chang Ho Lee, Youn Soo Jeon
www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.11.737 Original Article - Lasers in Urology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.11.737&domain=pdf&date_stamp=2014-11-16
More informationSubmitted: December 1, Accepted: Dec 24, Published: January 14, 2019.
Case Study DOI:10.22374/jeleu.v2i1.31 UROLIFT FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN A PATIENT WITH AMS 700 PENILE PROSTHESIS: THE FIRST REPORTED CASE Adam Jones, YC Phan, Wasim Mahmalji
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: January 15, 2019 Related Policies: None Prostatic Urethral Lift Description Benign prostatic hyperplasia (BPH) is a common condition in older individuals that
More informationLUTforum Highlights Christian Gratzke LMU Munich
LUTforum Highlights 2015 Christian Gratzke LMU Munich What is LUTforum? Web-based platform to provide specialists with highlights in functional urology presented at major urological congresses PowerPoint
More informationMODULE 3: BENIGN PROSTATIC HYPERTROPHY
MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student
More informationAPPENDIX CLINICAL INPUT RESPONSES
CLINICAL INPUT RESPONSES AUA: American Urological Association; UCSF Med Ctr: University of California San Francisco Medical Center; PUL: prostatic urethral lift. * Indicates that information on conflicts
More informationMedical Coverage Policy Prostatic Urethral Lifts
Medical Coverage Policy Prostatic Urethral Lifts EFFECTIVE DATE:01 01 2017 POLICY LAST UPDATED: 10 03 2017 OVERVIEW Benign prostatic hyperplasia is a common condition in older men that can lead to increased
More informationSurgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE
1 Approved by the AUA Board of Directors May 2018 Authors disclosure of potential conflicts of interest and author/staff contributions appear at the end of the article. 2018 by the American Urological
More informationName of Policy: Transurethral Microwave Thermotherapy
Name of Policy: Transurethral Microwave Thermotherapy Policy #: 449 Latest Review Date: September 2013 Category: Surgery Policy Grade: B Background/Definitions: As a general rule, benefits are payable
More informationAMERIHEALTH / INDEPENDENCE BLUE CROSS
AMERIHEALTH / INDEPENDENCE BLUE CROSS Urinary outlet obstruction is difficulty in the passage of urine from the bladder to the urethra caused by compression or resistance on the bladder outflow channel
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of transurethral water jet ablation for lower urinary tract symptoms caused by benign
More informationDurability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study
urologypracticejournal.com Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study Claus G. Roehrborn,*,y Steven N. Gange, y Neal D. Shore, Jonathan L. Giddens, Damien M. Bolton,
More informationBenign prostatic hyperplasia (BPH)
Diseases and Conditions Benign prostatic hyperplasia (BPH) By Mayo Clinic Staff Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate
More informationMedical Coverage Policy Prostatic Urethral Lifts
Medical Coverage Policy Prostatic Urethral Lifts EFFECTIVE DATE:12 01 2018 POLICY LAST UPDATED: 10 03 2017 OVERVIEW Benign prostatic hyperplasia is a common condition in older men that can lead to increased
More informationHealth technology adoption programme Published: 10 November 2015 nice.org.uk
NICE medical technology adoption support for UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia insights from the NHS Health technology adoption programme Published: 10 November
More informationTwo-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia
Research and Reports in Urology open access to scientific and medical research Open Access Full Text Article CLINICAL TRIAL REPORT Two-year results after convective radiofrequency water vapor thermal therapy
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,
More informationHow Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?
available at www.sciencedirect.com journal homepage: www.europeanurology.com How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?
More informationSurgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan
International Journal of Urology (2011) 18, 166 170 doi: 10.1111/j.1442-2042.2010.02687.x Short Communicationiju_2687 166..170 Surgical procedures for benign prostatic hyperplasia: A nationwide survey
More informationA PROMOTIONAL SUPPLEMENT TO FILLING THE GAP IN BPH CARE
A PROMOTIONAL SUPPLEMENT TO FILLING THE GAP IN BPH CARE Improving the BPH Care Pathway: The Prostatic Urethral Lift Procedure using the UroLift System Participants: Moderator: Claus G. Roehrborn, MD Professor
More informationResults. Conclusion. Keywords
Functional Urology Multicentre prospective crossover study of the prostatic urethral lift for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia Anthony L. Cantwell,
More informationGENDER HEALTH. Benign Prostatic Hyperplasia. Medical and Surgical Treatment Options
GENDER HEALTH Benign Prostatic Hyperplasia Medical and Surgical Treatment Options ABSTRACT Benign prostatic hyperplasia (BPH) affects the aging male. Treatment options vary widely. Some men will elect
More informationThulium Laser versus Standard Transurethral Resection of the Prostate: A Randomized Prospective Trial
european urology 53 (2008) 382 390 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Obstruction Thulium Laser versus Standard Transurethral Resection of the
More informationEarly-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP)
JRural Med 2007 ; 2 : 93 97 Original article Early-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP) Shuzo Hamamoto 1,TakehikoOkamura 1,HideyukiKamisawa 1,KentaroMizuno 1,
More informationProstate Artery Embolization
Prostate Artery Embolization in the office interventional suite Robert J. Kennedy, M.D. Interventional & Vascular Center Melbourne, Florida The speaker has no financial conflicts of interest to disclose.
More informationProstatic urethral lift: a novel approach for managing symptomatic BPH in the aging man Introduction: Materials and methods: Conclusion: Results:
Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man Daniel B. Rukstalis, MD Department of Urology, Wake Forest University School of Medicine, Winston-Salem, North Carolina,
More informationIncreasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP
Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of
More informationEAU GUIDELINES POCKET EDITION 3
EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books
More informationChapter 2: Methodology
Chapter 2: Methodology TABLE OF CONTENTS Introduction... 2 Study Selection and Data Abstraction... 2 Data Synthesis... 8 Guideline Development and Approvals... 9 Conflict of Interest... 10 Copyright 2010
More informationSubmitted: August 15, Accepted: September 10, Published: October 15, 2018.
Original Article doi: 10.22374/jeleu.v1i2.21 THULIUM LASER ENUCLEATION OF THE PROSTATE (THULEP) AS A TECHNIQUE FOR TREATMENT OF BPH: EVALUATION OF A SIX-YEAR EXPERIENCE AT A SINGLE INSTITUTION Mahmood
More informationBenign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary
Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,
More informationManagement of LUTS. Simon Woodhams February 2012
Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract
More informationBenign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran
Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark Studies Vijayan Manogran MTOPS & CombAT PLESS SMART ALTESS ALF-ONE VA PREDICT EPICS Landmark Studies MTOPS Medical Therapy of Prostatic Symptoms
More informationOUTCOMES OF HoLEP IN THE RETREATMENT SETTING
OUTCOMES OF HoLEP IN THE RETREATMENT SETTING Tracy Marien 1 MD, Mustafa Kadihasanoglu 1 MD, Teerayut Tangpaitoon 1 MD, Nadya York 2 MD, Andrew T. Blackburne 3 MD, Haidar Abdul-Muhsin 4 MD, Michael S. Borofsky
More informationMedical Technologies Evaluation Programme
Medical Technologies Evaluation Programme MT 241 - UroLift System for the treatment of symptoms of urinary outflow obstruction secondary to benign prostatic hyperplasia Expert Adviser Questionnaire Responses
More informationWednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario
Wednesday 25 June 14.30 15.30 Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario P080 Unreliable residual volume measurement after increased water load diuresis G. ALIVIZATOS, A. SKOLARIKOS,
More informationSurgical Treatment of LUTS in Men with BPE
Patient Information English 35 Surgical Treatment of LUTS in Men with BPE The underlined terms are listed in the glossary. You have been diagnosed with benign prostatic enlargement (BPE) and your doctor
More informationThe Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes
The Management of BPH & The Impact of Combination Therapy Results Combination of Avodart and Tamsulosin (CombAT) Medical Therapy of Prostate Symptoms (MTOPS) Dr. Jack Barkin, md, fics, facs, dabu, Mcert
More informationConsensus Meeting for Asian-Pacific BPH Guideline
Consensus Meeting for Asian-Pacific BPH Guideline Byung Ha Chung Yonsei University Health System S a t e l l i t e S y m p o s i u m I Contents Diagnosis and Treatment Guidelines for BPH Prostate Volume
More informationEvaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/10 Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients N. Narayanamoorthy,
More informationHolmium Laser Enucleation of the Prostate: Modified Morcellation Technique and Results
www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.11.779 Voiding Dysfunction Holmium Laser Enucleation of the Prostate: Modified Morcellation Technique and Results Su Hyung Lee, Jong In Choi, Kyung
More informationComparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study
original research Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study Jae Heon Kim, MD; * Jae Young Park,
More informationGUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)
GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (BPO) (Text update pril 2014) S. Gravas (chair),. Bachmann,. Descazeaud, M. Drake, C. Gratzke, S. Madersbacher, C. Mamoulakis,
More informationINJINTERNATIONAL. Original Article INTRODUCTION. Int Neurourol J 2017;21: pissn eissn
Official Journal of Korean Continence Society / Korean Society of Urological Research / The Korean Children s Continence and Enuresis Society / The Korean Association of Urogenital Tract Infection and
More informationGUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION
GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (Text update March 2015) S. Gravas (Chair), T. Bach,. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis,
More informationCan men with prostates sized 80 ml or larger be managed conservatively?
Original Article - Lower Urinary Tract Dysfunction Investig Clin Urol 2017;58:359-364. pissn 2466-0493 eissn 2466-054X Can men with prostates sized 80 ml or larger be managed conservatively? Alvin Lee,
More informationLUTS/BPH Medical and Surgical Management. Sung Tae Cho, MD, Ph.D Department of Urology Hallym University Kangnam Sacred Heart Hospital
LUTS/BPH Medical and Surgical Management Sung Tae Cho, MD, Ph.D Department of Urology Hallym University Kangnam Sacred Heart Hospital AUA Annual Meeting, 2013 Plenary : 8 Poster and Podium : 6 sessions
More informationDepartment of Urology, Nippon Medical School Chiba Hokusou Hospital, Chiba, Japan. Department of Urology, Nippon Medical School, Tokyo, Japan
Original Treatment Results of Transurethral Resection of the Prostate by Non-Japanese Board-Certified Urologists for Benign Prostate Hyperplasia: Analysis by Resection Volume Yasutomo Suzuki 1,2, Yuka
More informationInitial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj
Original Article Initial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj Abstract Objectives: Prospective evaluation
More informationThe Journal of International Medical Research 2012; 40:
The Journal of International Medical Research 2012; 40: 899 908 Comparison of α-blocker Monotherapy and α-blocker Plus 5α-Reductase Inhibitor Combination Therapy Based on Prostate Volume for Treatment
More informationEarly outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate
Singapore Med J 2016; 57(12): 676-680 doi: 10.11622/smedj.2016026 Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate Sundaram Palaniappan
More informationChapter 3: Results of the Treatment Outcomes Analyses
Chapter 3: Results of the Treatment Outcomes Analyses Introduction To determine the appropriateness of individual therapies, as well as to develop practice recommendations, the American Urological Association
More informationAs man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5
BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder
More informationEAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION
EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Text update March 2017) S. Gravas (Chair), T. Bach, M. Drake, M. Gacci, C. Gratzke, T.R.W. Herrmann, S. Madersbacher,
More information